Terms: = Prostate cancer AND MNX1, HB9, 3110, ENSG00000130675, P50219, HLXB9
16 results:
1. Clinical consequences of a genetic predisposition toward higher benign prostate-specific antigen levels.
Shi M; Shelley JP; Schaffer KR; Tosoian JJ; Bagheri M; Witte JS; Kachuri L; Mosley JD
EBioMedicine; 2023 Nov; 97():104838. PubMed ID: 37865044
[TBL] [Abstract] [Full Text] [Related]
2. lncRNA mnx1‑AS1 promotes prostate cancer progression through regulating miR‑2113/MDM2 axis.
Liang D; Tian C; Zhang X
Mol Med Rep; 2022 Jul; 26(1):. PubMed ID: 35616155
[TBL] [Abstract] [Full Text] [Related]
3. Stereotactic Pelvic Reirradiation for Locoregional cancer Relapse.
Kinj R; Doyen J; Hannoun-Lévi JM; Naghavi AO; Chand ME; Baudin G; Ferrero JM; François E; Evesque L; Borchiellini D; Benezery K; Bondiau PY
Clin Oncol (R Coll Radiol); 2021 Jan; 33(1):e15-e21. PubMed ID: 32641243
[TBL] [Abstract] [Full Text] [Related]
4. Retreatment for Local Recurrence of Prostatic Carcinoma After Prior Therapeutic Irradiation: Efficacy and Toxicity of HDR-Like SBRT.
Fuller D; Wurzer J; Shirazi R; Bridge S; Law J; Crabtree T; Mardirossian G
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):291-299. PubMed ID: 31629838
[TBL] [Abstract] [Full Text] [Related]
5. Knockdown of lncRNA mnx1-AS1 suppresses cell proliferation, migration, and invasion in prostate cancer.
Li Z; Wang F; Zhang S
FEBS Open Bio; 2019 May; 9(5):851-858. PubMed ID: 30980513
[TBL] [Abstract] [Full Text] [Related]
6. Knowledge, attitudes and screening practices regarding prostatic diseases among men older than 40 years: a population-based study in Southwest Nigeria.
Ojewola RW; Oridota ES; Balogun OS; Ogundare EO; Alabi TO; Banjo OO; Laoye A; Adetunmbi B; Adebayo BO; Oluyombo R
Pan Afr Med J; 2017; 27():151. PubMed ID: 28904679
[TBL] [Abstract] [Full Text] [Related]
7. RGS12 Is a Novel Tumor-Suppressor Gene in African American prostate cancer That Represses AKT and mnx1 Expression.
Wang Y; Wang J; Zhang L; Karatas OF; Shao L; Zhang Y; Castro P; Creighton CJ; Ittmann M
Cancer Res; 2017 Aug; 77(16):4247-4257. PubMed ID: 28611045
[TBL] [Abstract] [Full Text] [Related]
8. Search for genetic factor association with cancer-free prostate-specific antigen level elevation on the basis of a genome-wide association study in the Korean population.
Choe EK; Lee Y; Cho JY; Choi SH; Park B; Lee JE; Cho EY
Eur J Cancer Prev; 2018 Sep; 27(5):453-460. PubMed ID: 28471803
[TBL] [Abstract] [Full Text] [Related]
9. mnx1 Is Oncogenically Upregulated in African-American prostate cancer.
Zhang L; Wang J; Wang Y; Zhang Y; Castro P; Shao L; Sreekumar A; Putluri N; Guha N; Deepak S; Padmanaban A; Creighton CJ; Ittmann M
Cancer Res; 2016 Nov; 76(21):6290-6298. PubMed ID: 27578002
[TBL] [Abstract] [Full Text] [Related]
10. The augmented prophylactic antibiotic could be more efficacious in patients undergoing transrectal prostate biopsy: a systematic review and meta-analysis.
Yang L; Tang Z; Gao L; Li T; Chen Y; Liu L; Han P; Li X; Dong Q; Wei Q
Int Urol Nephrol; 2016 Aug; 48(8):1197-1207. PubMed ID: 27160220
[TBL] [Abstract] [Full Text] [Related]
11. Lower limb compartment syndrome as a complication of robot-assisted radical prostatectomy: the UK experience.
Pridgeon S; Bishop CV; Adshead J
BJU Int; 2013 Aug; 112(4):485-8. PubMed ID: 23879906
[TBL] [Abstract] [Full Text] [Related]
12. CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer.
Zambra FM; Biolchi V; Brum IS; Chies JA
Hum Immunol; 2013 Aug; 74(8):1003-8. PubMed ID: 23632061
[TBL] [Abstract] [Full Text] [Related]
13. Matched cohort analysis of outcomes of definitive radiotherapy for prostate cancer in human immunodeficiency virus-positive patients.
Kahn S; Jani A; Edelman S; Rossi P; Godette K; Landry J; Anderson C
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):16-21. PubMed ID: 22104362
[TBL] [Abstract] [Full Text] [Related]
14. Comparison of serum vascular endothelial growth levels between patients with and without ovarian malignancies.
Dehaven K; Taylor DD; Gercel-Taylor C
Int J Gynecol Cancer; 2002; 12(6):715-9. PubMed ID: 12445248
[TBL] [Abstract] [Full Text] [Related]
15. Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level < or = 10 ng/ml: radiation therapy or surgery?
Keyser D; Kupelian PA; Zippe CD; Levin HS; Klein EA
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):723-9. PubMed ID: 9240638
[TBL] [Abstract] [Full Text] [Related]
16. Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells.
Reile H; Armatis PE; Schally AV
Prostate; 1994 Jul; 25(1):29-38. PubMed ID: 8022709
[TBL] [Abstract] [Full Text] [Related]
